AbbVie Settlement Seems to End Period of Intense Scrutiny for Manufacturer Patient Support Programs
AbbVie has entered into a settlement agreement with the California Department of Insurance to resolve allegations that the pharmaceutical manufacturer violated the California Insurance Frauds Prevention Act by improperly marketing its product HUMIRA through the company's Nurse Educator Program.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.